Pharmaguy's Insights Into Drug Industry News
183.5K views | +26 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

An Open Letter to the BioPharma Community on Diversity from Execs at J.P. Morgan Healthcare Conference

An Open Letter to the BioPharma Community on Diversity from Execs at J.P. Morgan Healthcare Conference | Pharmaguy's Insights Into Drug Industry News | Scoop.it

An Open Letter to the BioPharma Community:

Now that it’s 2017, we are choosing to write this letter to provide recommendations for best practices to establish gender diversity as a priority for the biopharma industry.

 

Last year’s open letter to the industry sparked a dialogue that led to changes in some company practices, new training programs, regional gender diversity initiatives and much more. But we believe this is just the start of the work to be done.  

Below is the culmination of recent recommendations collected from industry executives for guiding principles and a top 10 list of best practices that we believe will continue the momentum of 2016 into 2017 and beyond.

 

Guiding Principles for Gender Diversity as a Priority for the BioPharma Industry:

  • We, as community leaders, commit to driving diversity and inclusion in the biopharma industry.
  • Diversity is good for the business performance of our industry.  Research proves that diversity leads to:
    • Better decision making
    • Increased productivity and financial performance
    • Enhanced engagement, recruitment and retention of talent
  • To ensure that the biopharma industry thrives and is sustainable, we, as community leaders, see it as our responsibility to drive diversity as a top priority.
  • Unconscious biases are ubiquitous and difficult to pinpoint and address. Still, we need to make a conscious commitment to eradicate unconscious biases in recruitment, performance evaluation, promotion and decision making in order to improve gender diversity.
  • While we recognize that there are many forms of diversity needed to ensure the future of our industry, there are clear best practices that can be implemented now to increase gender diversity.

 

Top Ten Best Practices for Increasing Gender Diversity in the BioPharma Industry:

  1. We as executives and board members declare gender diversity as a priority, as a key value and ethos.  We commit to living it visibly at all of our companies and organizations.
  2. We will create opportunities for open dialogue on enhancing gender diversity and ensuring an inclusive environment, both within our organizations and across the industry.
  3. We recognize the importance of formal sponsorship programs to ensure diversity in our executive leadership pipeline and commit to building these programs in our companies.
  4. We also recognize that it is important to provide formal mentorship programs to encourage women to engage with executives, both inside and outside of our organization. We commit to building these programs in our companies.
  5. We will ask our board members to be active sponsors of women who are “board ready” to pursue board appointments. We will endorse and sponsor our high potential female talent to take part in training programs to become “boardroom ready”.
  6. We will measure and track promotion of female talent to senior management positions.
  7. We will seek out and celebrate positive role models within our organizations.
  8. We will review our hiring processes and train our hiring managers on diversity and inclusion as a priority.
  9. We agree with the importance of setting concrete hiring goals to achieve gender parity and inclusion at each level of our organizations and to measure and report regularly on our progress towards goals.
  10. We will support the work of our trade organizations, like MassBio, on industry-wide efforts to improve gender diversity at the macro level.

 

We, as community leaders, have the responsibility to ensure our biopharma industry can continue to grow and thrive.  We need to take a holistic view on the next generation of leaders to prepare for the future. We believe that diversity and inclusion will deliver better results for our industry and society.  We have the opportunity and the responsibility to lead by example, setting the tone and pace for the biopharma industry.

 

We invite you to join us, to sign this open letter, and to work to implement these practices to ensure the continued success of our industry.

more...
Scooped by Pharma Guy
Scoop.it!

Biopharma Gets a "D" Grade for Gender Diversity in Exec Suite

Biopharma Gets a "D" Grade for Gender Diversity in Exec Suite | Pharmaguy's Insights Into Drug Industry News | Scoop.it
The biopharma industry doesn't do a very good job when it comes down to the way it handles gender diversity. And if you're a woman in this business, chances are you have a distinctly bleaker view of things than your male colleagues. That's the bottom line from last week's informal survey from FierceBiotech.
more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Healthcare Agency Recruitment: A New Breed, Yes, But Still Little Race Diversity

Healthcare Agency Recruitment: A New Breed, Yes, But Still Little Race Diversity | Pharmaguy's Insights Into Drug Industry News | Scoop.it

What do healthcare agencies really want when it comes to potential employees The answer to that question is in a constant state of flux, as technologies, clients changing demands and the everexpanding skill sets of a new generation of job seekers are transforming the rules of recruitment and hiring.


Maybe it's reductive to bunch Daryl Somma, Shwen Gwee and Nathan Stewart under a single heading. Beyond being exceedingly good at their jobs, the three have only a single thing in common—namely, that in terms of professional background, they have nothing in common, with each other or the great majority of their agency peers. Yet that's what makes them comrades of a kind and flag-bearers for the New Breed, for the type of employee whose unusual mix of ability, acumen and personality is prompting agency HR folks to rethink what they look for in a job candidate.

Pharma Guy's insight:


One thing not mentioned in this article is that most agencies do not hire people of color. Read: Pharma Vendor and Ad Agency Diversity: All Talk, No Action? and Diversity in the Life Sciences

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

To Achieve Gender Diversity in #Pharma, Let Women Speak w/o Interruption! Hear that Donald?

To Achieve Gender Diversity in #Pharma, Let Women Speak w/o Interruption! Hear that Donald? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Whatever your politics, it’s clear that many women don’t feel understood in a society dominated by men in positions of power, whether corporate or political. And biopharma has had its own controversy, in early 2016, when some rankly sexist behavior at the J.P. Morgan Healthcare Conference triggered a backlash among some prominent women--and men--in the business.

 

At the time, FierceBiotech asked readers to give the industry a letter grade for gender diversity. The results were "stark," as one of our past Women in Biopharma told me recently. Sixty percent of women gave the industry a D or an F, and 28% more awarded a C. That’s 88% in a range no student would want on a transcript.

 

Men, on the other hand, gave biopharma an A or B for gender diversity.

 

In hopes of finding out more, in September, we presented a panel on women in the industry at the FierceBiotech Drug Development Forum in Boston. With four of our previous Women in Biopharma on hand to talk for an hour about their own experiences--and offer some ideas for better times ahead--a picture emerged of an industry that’s saying all the right things about gender balance and diversity of all kinds.

 

Our panelists agreed that, if the pace of change continues as it is now, decades will pass before biopharma can boast anything like gender balance. The above-and-beyond hiring efforts, for one. More extensive child-care benefits, for another. But because expectations of women are cultural--and real cultural change takes time--it could be education is even more important. As an audience member in Boston pointed out, education that starts even in preschool.

 

While we’re waiting for a newly enlightened generation to grow up, however, some nitty-gritty workplace education could help. Consider interrupting--a topical subject. Women and men can both be taught to challenge that sort of behavior when it comes up. “Often women are talked over,” Protopapas said. “If both men and women would step in and say, ‘let them speak,’ that would call out bad behavior in front of everybody.”

Pharma Guy's insight:

Also read: "Women Execs Matter! Poor Gender Diversity in Biotech Boardrooms"; http://sco.lt/56WjUv 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Women Execs Matter! Poor Gender Diversity in Biotech Boardrooms

Women Execs Matter! Poor Gender Diversity in Biotech Boardrooms | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Only 23 out of 106 seats are held by women. That's a paltry 21%


To increase gender diversity at a Morgan biotech industry party, organizers hired scantily clad models to work the room.


Sign the Letter & Tell J.P. Morgan You Support Gender Diversity in the Life Sciences: http://sco.lt/8611px 


Pharma Guy's insight:

Join the Pharma digital women influencers TweetChat (#dswpharma) on Weds, 17 Feb 2016, 1 PM EST.

more...
No comment yet.